Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Clemens WA"'
Autor:
Anne Müller, Fabian Hebben, Kim Dillen, Veronika Dunkl, Yasemin Goereci, Raymond Voltz, Peter Löcherbach, Clemens Warnke, Heidrun Golla, on behalf of the COCOS-MS trial group represented by Martin Hellmich
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-15 (2024)
Abstract Background Persons with severe Multiple Sclerosis (PwsMS) face complex needs and daily limitations that make it challenging to receive optimal care. The implementation and coordination of health care, social services, and support in financia
Externí odkaz:
https://doaj.org/article/59ee9fce8bca4b64ade155f845eb01f8
Autor:
Fabian Boesl, Yasemin Goereci, Finja Schweitzer, Carsten Finke, Ann-Katrin Schild, Stefan Bittner, Falk Steffen, Maria Schröder, Anneke Quitschau, Josephine Heine, Clemens Warnke, Christiana Franke
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Cognitive impairment is the most frequent symptom reported in post-COVID-19 syndrome (PCS). Aetiology of cognitive impairment in PCS is still to be determined. Neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) are in
Externí odkaz:
https://doaj.org/article/2ed838f95d69483f9b244a397b22a402
Autor:
Niklas Frahm, David Ellenberger, Alexander Stahmann, Firas Fneish, Daniel Lüftenegger, Hans C. Salmen, Ksenija Schirduan, Tom P. A. Schaak, Peter Flachenecker, Christoph Kleinschnitz, Friedemann Paul, Dagmar Krefting, Uwe K. Zettl, Melanie Peters, Clemens Warnke
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 17 (2024)
Background: The spectrum of disease-modifying therapies (DMTs) for people with multiple sclerosis (PwMS) has expanded over years, but data on treatment strategies is largely lacking. DMT switches are common clinical practice. Objective: To compare sw
Externí odkaz:
https://doaj.org/article/c8eeaeea69924efc9284aba8da3cbdca
Autor:
Alexander Stahmann, Elaine Craig, David Ellenberger, Firas Fneish, Niklas Frahm, Ruth Ann Marrie, Rod Middleton, Richard Nicholas, Jeff Rodgers, Clemens Warnke, Amber Salter
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 17 (2024)
Background: Treatment guidelines recommend early disease-modifying therapy (DMT) initiation after diagnosis of multiple sclerosis (MS). Multinational comparative studies that assess time to DMT initiation in MS may allow detection of barriers inheren
Externí odkaz:
https://doaj.org/article/85e9dcff225c45649ad0ca9d2536773d
Publikováno v:
Europe's Journal of Psychology, Vol 18, Iss 4, Pp 350-356 (2022)
Many patients that were infected with SARS-CoV-2 experience cognitive and affective symptoms weeks and months after their acute COVID-19 disease, even when acute symptoms were mild to moderate. For these patients, purely neurological explanations are
Externí odkaz:
https://doaj.org/article/7f1691fc6b2943479bda479fed9f972d
Autor:
Antonios Bayas, Achim Berthele, Norbert Blank, Peter Dreger, Simon Faissner, Manuel A. Friese, Lisa-Ann Gerdes, Oliver Martin Grauer, Vivien Häussler, Christoph Heesen, Dietlinde Janson, Mirjam Korporal-Kuhnke, Markus Kowarik, Nikolaus Kröger, Jan D. Lünemann, Roland Martin, Uwe Meier, Sven Meuth, Paolo Muraro, Michael Platten, Lucas Schirmer, Klarissa Hanja Stürner, Jan Patrick Stellmann, Christof Scheid, Florian Then Bergh, Clemens Warnke, Brigitte Wildemann, Tjalf Ziemssen
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 16 (2023)
Background: While substantial progress has been made in the development of disease-modifying medications for multiple sclerosis (MS), a high percentage of treated patients still show progression and persistent inflammatory activity. Autologous haemat
Externí odkaz:
https://doaj.org/article/9ebac6238a0044049f1e01a530d4bd56
Autor:
Marit L. Schlagheck, Sven T. Hübner, Niklas Joisten, David Walzik, Annette Rademacher, Florian Wolf, Jens Bansi, Clemens Warnke, Philipp Zimmer
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
IntroductionBased on theoretical models, physical activity has been introduced as a promoting method to mitigate the disease severity, fatigue and relapse rate in multiple sclerosis. The primary objective of the study was to investigate the relation
Externí odkaz:
https://doaj.org/article/dd1c7400e6864b6eb5ec2560b551594d
Autor:
Yasemin Goereci, Nina N. Kleineberg, Marie Madlener, Hannah Neuschmelting, Gereon R. Fink, Clemens Warnke, Henning Stetefeld
Publikováno v:
Neurological Research and Practice, Vol 3, Iss 1, Pp 1-4 (2021)
Abstract The ChAdOx1 nCoV-19 adenoviral vector vaccine to prevent contracting Covid-19 caused by infection with SARS-CoV-2 has been associated with vaccine-induced immune thrombotic thrombocytopenia (VITT) primarily leading to venous thromboses. Here
Externí odkaz:
https://doaj.org/article/171a9b23a5b14c2b87aedfbf6356a6dc
Autor:
Clemens Warnke, Tomas Olsson, Ingrid Kockum, Tomas Bergström, Anna Fogdell-Hahn, Linn Persson Berg, Marcus Eriksson, Sonia Longhi, Elisabeth Thomsson, Malin Bäckström
Publikováno v:
BMJ Neurology Open, Vol 4, Iss 2 (2022)
Background Patients with multiple sclerosis (MS) demonstrate higher seroprevalence of Epstein-Barr virus (EBV) and increased anti-EBV IgG levels in serum compared with healthy controls. Intrathecal antibody production to measles virus (MeV) is a comm
Externí odkaz:
https://doaj.org/article/f519929a3bea4ac79ec20150e732034d
Autor:
Lisa-Marie Ohle, David Ellenberger, Peter Flachenecker, Tim Friede, Judith Haas, Kerstin Hellwig, Tina Parciak, Clemens Warnke, Friedemann Paul, Uwe K. Zettl, Alexander Stahmann
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract In 2001, the German Multiple Sclerosis Society, facing lack of data, founded the German MS Registry (GMSR) as a long-term data repository for MS healthcare research. By the establishment of a network of participating neurological centres of
Externí odkaz:
https://doaj.org/article/3654845ac2f64275b780abb489f96ac1